JAWAHARLAL NEHRU TECHNOLOGICAL UNIVERSITY HYDERABAD Pharm. D V Year CLINICAL RESEARCH Previous Question Paper (July/August - 2021 - R08)

Drug characterization is a critical phase in drug discovery that involves the comprehensive identification and quantification of the physicochemical properties of a lead compound. This process ensures the molecule is suitable for further development and clinical testing. Key aspects include:

• Structural Elucidation: Utilizing techniques like Nuclear Magnetic Resonance (NMR), Mass Spectrometry (MS), and X-ray crystallography to confirm the chemical structure and purity of the molecule.
• Physicochemical Profiling: Determining solubility, lipophilicity (LogP), pKa, and stability under various pH and temperature conditions. These factors directly influence the drug's bioavailability and membrane permeability.
• Solid-State Characterization: Investigating polymorphism, crystallinity, and particle size distribution, which are essential for consistent manufacturing and dissolution performance.
• Impurity Profiling: Identifying and quantifying potential degradation products or synthesis-related impurities to ensure safety and regulatory compliance.

The development of a dosage form is the process of transforming a drug substance into a stable, effective, and patient-compliant medicinal product. This stage bridges the gap between laboratory discovery and clinical application. The approach involves:

• Pre-formulation Studies: Assessing the compatibility of the drug with various excipients to prevent chemical interactions that could compromise stability or efficacy.
• Selection of Delivery Route: Determining the optimal route of administration (e.g., oral, parenteral, topical) based on the drug's pharmacokinetic profile, therapeutic target, and patient convenience.
• Formulation Design: Incorporating appropriate excipients such as binders, disintegrants, lubricants, or stabilizers to ensure the drug is delivered in a predictable and reproducible manner.
• Stability Testing: Conducting accelerated and long-term stability studies according to ICH guidelines to determine the shelf-life and appropriate packaging requirements for the dosage form.
• Bioavailability Optimization: Utilizing technologies like micronization, solid dispersions, or controlled-release mechanisms to enhance the absorption and therapeutic index of the drug.